HCG gains with associate company inking agreement with Quest Diagnostics

11 Oct 2018 Evaluate

Healthcare Global Enterprises is currently trading at Rs. 216.15, up by 1.05 points or 0.49% from its previous closing of Rs. 215.10 on the BSE.

The scrip opened at Rs. 249.00 and has touched a high and low of Rs. 249.00 and Rs. 215.00 respectively. So far 78 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 352.00 on 31-Jan-2018 and a 52 week low of Rs. 200.00 on 03-Oct-2018.

Last one week high and low of the scrip stood at Rs. 249.00 and Rs. 205.45 respectively. The current market cap of the company is Rs. 1888.89 crore.

The promoters holding in the company stood at 24.85%, while Institutions and Non-Institutions held 58.13% and 17.03% respectively.

HealthCare Global Enterprises’ (HCG) associate company -- Strand Life Sciences has entered into an agreement to acquire the India medical diagnostics business of Quest Diagnostics, the world's leading provider of diagnostic information services.

The two companies will work together to manage the transition, and aim to close the sale by the end of first quarter of calendar year 2019. This acquisition is an important addition to the company’s network of 24 diagnostic labs across India, especially as they continue to expand their work in oncology, genomics, and precision medicine.

HCG is the largest provider of cancer care in India. Through its network of comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.

HealthcareGlobal Share Price

498.45 -0.15 (-0.03%)
15-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6694.40
Max Healthcare Inst 1039.35
Narayana Hrudayalay 1287.85
Aster DM Healthcare 489.85
Global Health 1023.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.